Literature DB >> 25378553

'Neonatal' Nav1.2 reduces neuronal excitability and affects seizure susceptibility and behaviour.

Elena V Gazina1, Bryan T W Leaw2, Kay L Richards2, Verena C Wimmer2, Tae H Kim2, Timothy D Aumann2, Travis J Featherby2, Leonid Churilov2, Vicki E Hammond2, Christopher A Reid2, Steven Petrou3.   

Abstract

Developmentally regulated alternative splicing produces 'neonatal' and 'adult' isoforms of four Na(+) channels in human brain, NaV1.1, NaV1.2, NaV1.3 and NaV1.6. Heterologously expressed 'neonatal' NaV1.2 channels are less excitable than 'adult' channels; however, functional importance of this difference is unknown. We hypothesized that the 'neonatal' NaV1.2 may reduce neuronal excitability and have a seizure-protective role during early brain development. To test this hypothesis, we generated NaV1.2(adult) mice expressing only the 'adult' NaV1.2, and compared the firing properties of pyramidal cortical neurons, as well as seizure susceptibility, between the NaV1.2(adult) and wild-type (WT) mice at postnatal day 3 (P3), when the 'neonatal' isoform represents 65% of the WT NaV1.2. We show significant increases in action potential firing in NaV1.2(adult) neurons and in seizure susceptibility of NaV1.2(adult) mice, supporting our hypothesis. At postnatal day 15 (P15), when 17% of the WT NaV1.2 is 'neonatal', the firing properties of NaV1.2(adult) and WT neurons converged. However, inhibitory postsynaptic currents in NaV1.2(adult) neurons were larger and the expression level of Scn2a mRNA was 24% lower compared with the WT. The enhanced seizure susceptibility of the NaV1.2(adult) mice persisted into adult age. The adult NaV1.2(adult) mice also exhibited greater risk-taking behaviour. Overall, our data reveal a significant impact of 'neonatal' NaV1.2 on neuronal excitability, seizure susceptibility and behaviour and may contribute to our understanding of NaV1.2 roles in health and diseases such as epilepsy and autism.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25378553     DOI: 10.1093/hmg/ddu562

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  26 in total

1.  The Autism-Associated Gene Scn2a Contributes to Dendritic Excitability and Synaptic Function in the Prefrontal Cortex.

Authors:  Perry W E Spratt; Roy Ben-Shalom; Caroline M Keeshen; Kenneth J Burke; Rebecca L Clarkson; Stephan J Sanders; Kevin J Bender
Journal:  Neuron       Date:  2019-06-20       Impact factor: 17.173

2.  Sodium channel subtypes are differentially localized to pre- and post-synaptic sites in rat hippocampus.

Authors:  Kenneth W Johnson; Karl F Herold; Teresa A Milner; Hugh C Hemmings; Jimcy Platholi
Journal:  J Comp Neurol       Date:  2017-08-11       Impact factor: 3.215

3.  De novo and inherited SCN8A epilepsy mutations detected by gene panel analysis.

Authors:  Kameryn M Butler; Cristina da Silva; Yuval Shafir; James D Weisfeld-Adams; John J Alexander; Madhuri Hegde; Andrew Escayg
Journal:  Epilepsy Res       Date:  2016-11-06       Impact factor: 3.045

Review 4.  Autism spectrum disorder: neuropathology and animal models.

Authors:  Merina Varghese; Neha Keshav; Sarah Jacot-Descombes; Tahia Warda; Bridget Wicinski; Dara L Dickstein; Hala Harony-Nicolas; Silvia De Rubeis; Elodie Drapeau; Joseph D Buxbaum; Patrick R Hof
Journal:  Acta Neuropathol       Date:  2017-06-05       Impact factor: 17.088

5.  Opposing Effects on NaV1.2 Function Underlie Differences Between SCN2A Variants Observed in Individuals With Autism Spectrum Disorder or Infantile Seizures.

Authors:  Roy Ben-Shalom; Caroline M Keeshen; Kiara N Berrios; Joon Y An; Stephan J Sanders; Kevin J Bender
Journal:  Biol Psychiatry       Date:  2017-01-27       Impact factor: 13.382

6.  Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model.

Authors:  Melody Li; Nikola Jancovski; Paymaan Jafar-Nejad; Lisseth E Burbano; Ben Rollo; Kay Richards; Lisa Drew; Alicia Sedo; Jacqueline Heighway; Svenja Pachernegg; Armand Soriano; Linghan Jia; Todd Blackburn; Blaine Roberts; Alex Nemiroff; Kelley Dalby; Snezana Maljevic; Christopher A Reid; Frank Rigo; Steven Petrou
Journal:  J Clin Invest       Date:  2021-12-01       Impact factor: 14.808

Review 7.  A matter of space and time: Emerging roles of disease-associated proteins in neural development.

Authors:  Georgia Panagiotakos; Sergiu P Pasca
Journal:  Neuron       Date:  2021-11-29       Impact factor: 17.173

Review 8.  Role of Sodium Channels in Epilepsy.

Authors:  David I Kaplan; Lori L Isom; Steven Petrou
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

Review 9.  Progress in Understanding and Treating SCN2A-Mediated Disorders.

Authors:  Stephan J Sanders; Arthur J Campbell; Jeffrey R Cottrell; Rikke S Moller; Florence F Wagner; Angie L Auldridge; Raphael A Bernier; William A Catterall; Wendy K Chung; James R Empfield; Alfred L George; Joerg F Hipp; Omar Khwaja; Evangelos Kiskinis; Dennis Lal; Dheeraj Malhotra; John J Millichap; Thomas S Otis; Steven Petrou; Geoffrey Pitt; Leah F Schust; Cora M Taylor; Jennifer Tjernagel; John E Spiro; Kevin J Bender
Journal:  Trends Neurosci       Date:  2018-04-23       Impact factor: 13.837

Review 10.  Dysfunction of the corticostriatal pathway in autism spectrum disorders.

Authors:  Wei Li; Lucas Pozzo-Miller
Journal:  J Neurosci Res       Date:  2019-11-22       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.